EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors.
The Presenting Companies track provides a pipeline to innovative companies interested in partnering their technologies or products, initiating strategic alliances, or tapping into the international financing network. In addition, early stage projects and small entrepreneurial companies can present their novel ideas to large medtech, pharma, and investors in the Next Generation track.
A preliminary list of presenting companies has just been released, and includes industry innovators such as Acarix A/S; AFreeze; Avalon Health Economics; CiToxLAB Scantox; ConsulTech GmbH; CVTEC; Humedics GmbH; Implandata Ophthalmic Products GmbH; ImPress MedTech e.U.; Inventram/Tarabios; iSTAR Medical SA; J A Kemp; Johns Hopkins University; LevOss; LIVEcheck - Global Diagnostics; Michelson Diagnostics Ltd; Reapplix; Sagentia; Senzime; Sheltagen Medical Ltd; Software Quality Lab GmbH; Transcatheter Technologies GmbH.
“iSTAR has introduced an innovative ophthalmic implant made from STAR® Biomaterial and has partnered with international distributors that were initially met at EuroMedtech 2012,” said Michel Alvarez, CEO of iSTAR Medical. “Presenting again will put us in front of new potential partners and investors interested in our current product and our robust development pipeline.”
“There is a huge market demand for technologies to treat chronic wounds, particularly diabetic wounds,” said Niels Erik Holm, Founder and CEO of Reapplix. “Our expected exit time is past the completion of our Randomized Controlled Trial, however, in the meantime we would like to discuss market access/reimbursement and commercialization strategies with potential partners. EuroMedtech puts us in front of the right people.”
Produced by EBD Group, EuroMedtech caters to companies involved in all parts of the advanced medical technology industry, from those serving mainline therapeutic categories such as drug delivery and augmented intervention in medicine, through diagnostics, imaging and eHealth to those involved in platform technologies such as micro and nanotechnological tools and implantable devices.
The 2013 event attracted 261 dealmakers from 191 companies who participated in 600 one-to-one meetings. The event also featured presentations by 44 of the most exciting medtech companies in Europe.
Presentation and registration information for EuroMedtech 2014 is available online. Registration closes May 5, 2014, 18:00 CET, after which all registrations will be handled on site.
Follow EuroMedtech on Twitter: @EuroMedtech, hashtag #EMT14.
Or join the Medtech Industry Group on partnering360® to kick off your partnering activities before EuroMedtech, and throughout the year. partnering360 is a dynamic network of life science industry experts that will enable you to continue the dialogue from your partneringONE meetings at events and identify and connect with new partners anytime, year-round. Join the vibrant community of medtech companies on partnerning360 today.
About the Health Technology Cluster
The Health Technology Cluster (HC) is an inter-sectoral network for increasing innovative capacity and international competitiveness of Health Technology companies, their suppliers as well as relevant research and healthcare facilities. The HC currently connect 220 partner companies from Austria and South Germany. Due to the Upper Austrian strength in medical technology, the main focus is on medical electronics, software, clean room & hygiene, hospital equipment, end-user products, diagnostics-pharma and materials (metal/plastics). More detailed information under www.gesundheitstechnologie-cluster.at.
Please find the digital version under www.gesundheitstechnologie-cluster.at/presse
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.